Jim Simons' highly respected quantitative fund, Renaissance Technologies, has completely exited its position in Thermo Fisher Scientific (TMO). According to its latest 13F filing, the firm sold all 138,960 of its shares, a stake previously valued at $68.30 million. The sale is notable given that during the same quarter, Thermo Fisher reported strong financial results, with a 10% revenue increase to $11.99 billion and a 13% rise in adjusted earnings per share.
This disclosure, filed on August 13, 2026, reflects the fund's holdings as of June 30, 2026. Therefore, the trades occurred at some point during the second quarter. Thermo Fisher, a major provider of scientific instruments and laboratory services, raised its full-year financial outlook following its robust quarterly performance.